North America Dry Eye Syndrome Market

Market Overview:

The North America dry eye syndrome market size reached US$ 2.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2027, exhibiting a growth rate (CAGR) of 5.9% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Dry eye syndrome, also known as keratoconjunctivitis sicca, is a multifactorial tear deficiency disorder of the ocular surface. It is a commonly encountered condition in general ophthalmology practice and entails the lack of a consistent and adequate layer of tears on the eye surface. Dry eye syndrome exhibits a range of symptoms including burning sensation, itchy eyes, inflammation, aching sensations, heaviness, fatigue, soreness, dryness, redness, photophobia and blurred vision. This disease is curable by medicines that are generally available in the form of gels, ointments, liquid drops and wipes.

North America dry eye syndrome market is currently driven by several factors. The changing lifestyles of individuals, especially the increased usage of electronic gadgets, such as computers and TV, has led to a rise in the prevalence of dry eye syndrome. In addition to this, the escalated usage of contact lens among the majority of the population has resulted in the increasing risk of dry eye syndrome. Moreover, the rising geriatric population has become prone to health conditions such as high blood pressure and benign prostatic hyperplasia, which further induces the risk of developing dry eye syndrome. Apart from this, the rapid advancements in the healthcare sector have enabled the easy availability of dry eye syndrome treatment, thus positively influencing the demand in the region.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the North America dry eye syndrome market report, along with forecasts at the regional and country level from 2022-2027. Our report has categorized the market based on disease type, drug type, product and distribution channel.

• Key Regions Analysed
  • United States
  • Canada
     
• Analysis for Each Country
   
• Market by Disease Type
  • Evaporative Dry Eye Syndrome
  • Aqueous Dry Eye Syndrome
     
• Market by Drug Type
  • Lubricant Eye Drops
  • Anti-inflammatory Drugs
  • Autologous Serum Eye Drops
  • Others
     
• Market by Product
  • Liquid Drops
  • Gels
  • Liquid Wipes
  • Eye Ointments
  • Others
     
• Market by Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
     
• Value Chain Analysis
• Key Drivers and Challenges
• Porters Five Forces Analysis
• Competitive Landscape
  • Competitive Structure
  • Key Player Profiles

Report Coverage:

Key Questions Answered in This Report:

• How has the North America dry eye syndrome market performed so far and how will it perform in the coming years?
• What are the key regions in the North America dry eye syndrome market?
• What has been the impact of COVID-19 on the North America dry eye syndrome market?
• What is the breakup of the North America dry eye syndrome market on the basis of disease type?
• What is the breakup of the North America dry eye syndrome market on the basis of drug type?
• What is the breakup of the North America dry eye syndrome market on the basis of product?
• What is the breakup of the North America dry eye syndrome market on the basis of distribution channel?
• What are the various stages in the value chain of the North America dry eye syndrome industry?
• What are the key driving factors and challenges in the North America dry eye syndrome industry?
• What is the structure of the North America dry eye syndrome industry and who are the key players?
• What is the degree of competition in the North America dry eye syndrome industry?
• What are the profit margins in the North America dry eye syndrome industry?